Paying Tribute To His Late Father
- 34-year-old Yahya Abdul-Mateen II won his first Emmy for HBO’s Watchmen and remembered his father in his acceptance speech.
- The Yale-educated actor decided to study acting following the loss of his father to cancer.
- “I was 21, and my best friend had died,” Mateen II has said of losing his dad.
Abdul-Mateen, winning for his powerful turn on HBO’s Watchman thanked his late father, who died of cancer, in his acceptance speech:Read More
Mateen II has not disclosed publicly the type of cancer his father was diagnosed with. He recalled that period of loss in a Time magazine interview.
"In my mind it was like 'He'll pull through.' When he didn't, I didn't understand. I was 21, and my best friend had died. The worst thing that could happen happened, so it taught me to do the thing that makes me happy and to really chase my dreams."
The loss shook his tightknit family, reports The Wall Street Journal. And it was incredibly hard on young Yahya. A few years after the loss of his dad, Mateen II was accepted into the esteemed Yale School of Drama and decided to give it a shot. Of acting, he said, "I'm going to give myself three years to make significant progress." And progress he did make.
View this post on Instagram
WOW!! WOW!! WOAH!! This is real!! I JUST GOT NOMINATED FOR AN EMMY, y'all!! ðŸ¤¯ Feels so good to be acknowledged for my work by The Academy and my peers. Thank you so much! And thank you to @damonlindelof, @nicolekassell, my HBO main thang @iamreginaking ðŸ˜‚ the entire writing staff and creative team and the FANS of our show who watched every week and engaged in the important dialogue. I appreciate you! Congrats as well to my fellow nominees! Humbled, Grateful, and EXCITED! I can't stop smiling! #Emmys #BestSupportingActor #LimitedSeries
In the face of unthinkable loss, Mateen II used the grief to propel him to new heights. His father is surely watching proudly as the actor did not succumb to grief, but instead, worked hard at his craft to make his late father proud.
Disparities in Cancer Treatment For Minorities
There are disparities in cancer care and treatment for minority groups in the U.S., with stark statistics like: Black men in America are 50% more likely to die of prostate cancer than other races.
Dr. Ted Teknos writes for SurvivorNet that “Compared to the general population, Black patients and other minorities are underrepresented in clinical trials. It's imperative this changes; opening up these clinical trials to a wider range of minorities could increase their chances of survival.”